nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinephrine—TNF—acquired immunodeficiency syndrome	0.334	1	CbGaD
Epinephrine—SLC22A1—Indinavir—acquired immunodeficiency syndrome	0.0353	0.0767	CbGbCtD
Epinephrine—SLC22A1—Nelfinavir—acquired immunodeficiency syndrome	0.0342	0.0744	CbGbCtD
Epinephrine—SLC22A2—Zidovudine—acquired immunodeficiency syndrome	0.0342	0.0743	CbGbCtD
Epinephrine—SLC22A1—Saquinavir—acquired immunodeficiency syndrome	0.031	0.0673	CbGbCtD
Epinephrine—SLC22A2—Lamivudine—acquired immunodeficiency syndrome	0.0264	0.0575	CbGbCtD
Epinephrine—SLC22A1—Lamivudine—acquired immunodeficiency syndrome	0.023	0.0499	CbGbCtD
Epinephrine—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0168	0.0366	CbGbCtD
Epinephrine—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0158	0.0344	CbGbCtD
Epinephrine—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0158	0.0344	CbGbCtD
Epinephrine—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0152	0.033	CbGbCtD
Epinephrine—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0143	0.0311	CbGbCtD
Epinephrine—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0143	0.031	CbGbCtD
Epinephrine—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0143	0.031	CbGbCtD
Epinephrine—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0129	0.028	CbGbCtD
Epinephrine—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0129	0.028	CbGbCtD
Epinephrine—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.012	0.0261	CbGbCtD
Epinephrine—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0111	0.0242	CbGbCtD
Epinephrine—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0108	0.0236	CbGbCtD
Epinephrine—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0108	0.0235	CbGbCtD
Epinephrine—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.00978	0.0213	CbGbCtD
Epinephrine—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.00978	0.0213	CbGbCtD
Epinephrine—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00937	0.0204	CbGbCtD
Epinephrine—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00882	0.0192	CbGbCtD
Epinephrine—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00829	0.018	CbGbCtD
Epinephrine—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00829	0.018	CbGbCtD
Epinephrine—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0075	0.0163	CbGbCtD
Epinephrine—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0075	0.0163	CbGbCtD
Epinephrine—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00647	0.0141	CbGbCtD
Epinephrine—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00629	0.0137	CbGbCtD
Epinephrine—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00568	0.0124	CbGbCtD
Epinephrine—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00568	0.0124	CbGbCtD
Epinephrine—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00545	0.0118	CbGbCtD
Epinephrine—ADRBK1—blood plasma—acquired immunodeficiency syndrome	0.00264	0.0702	CbGeAlD
Epinephrine—TNF—blood—acquired immunodeficiency syndrome	0.00168	0.0448	CbGeAlD
Epinephrine—TNF—vagina—acquired immunodeficiency syndrome	0.00156	0.0415	CbGeAlD
Epinephrine—PAH—blood—acquired immunodeficiency syndrome	0.00127	0.0337	CbGeAlD
Epinephrine—PAH—nervous system—acquired immunodeficiency syndrome	0.00103	0.0273	CbGeAlD
Epinephrine—ADRBK1—lymphoid tissue—acquired immunodeficiency syndrome	0.00103	0.0273	CbGeAlD
Epinephrine—ADRBK1—digestive system—acquired immunodeficiency syndrome	0.00101	0.027	CbGeAlD
Epinephrine—TNF—lymph node—acquired immunodeficiency syndrome	0.00101	0.0268	CbGeAlD
Epinephrine—PAH—central nervous system—acquired immunodeficiency syndrome	0.000989	0.0263	CbGeAlD
Epinephrine—ADRBK1—blood—acquired immunodeficiency syndrome	0.000966	0.0257	CbGeAlD
Epinephrine—ADRBK1—bone marrow—acquired immunodeficiency syndrome	0.000935	0.0249	CbGeAlD
Epinephrine—ADRBK1—vagina—acquired immunodeficiency syndrome	0.000895	0.0238	CbGeAlD
Epinephrine—ADRBK1—lung—acquired immunodeficiency syndrome	0.000847	0.0225	CbGeAlD
Epinephrine—PAH—brain—acquired immunodeficiency syndrome	0.000785	0.0209	CbGeAlD
Epinephrine—ADRBK1—nervous system—acquired immunodeficiency syndrome	0.000784	0.0209	CbGeAlD
Epinephrine—ADRBK1—central nervous system—acquired immunodeficiency syndrome	0.000755	0.0201	CbGeAlD
Epinephrine—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.000721	0.0192	CbGeAlD
Epinephrine—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000684	0.0182	CbGeAlD
Epinephrine—ADRA2A—blood plasma—acquired immunodeficiency syndrome	0.000663	0.0176	CbGeAlD
Epinephrine—SLC22A2—digestive system—acquired immunodeficiency syndrome	0.000624	0.0166	CbGeAlD
Epinephrine—ADRBK1—brain—acquired immunodeficiency syndrome	0.000599	0.0159	CbGeAlD
Epinephrine—ADRBK1—lymph node—acquired immunodeficiency syndrome	0.000579	0.0154	CbGeAlD
Epinephrine—Acute coronary syndrome—Amprenavir—acquired immunodeficiency syndrome	0.000557	0.0047	CcSEcCtD
Epinephrine—Myocardial infarction—Amprenavir—acquired immunodeficiency syndrome	0.000554	0.00467	CcSEcCtD
Epinephrine—Lightheadedness—Efavirenz—acquired immunodeficiency syndrome	0.000546	0.00461	CcSEcCtD
Epinephrine—Drug interaction—Lamivudine—acquired immunodeficiency syndrome	0.000534	0.00451	CcSEcCtD
Epinephrine—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000522	0.0139	CbGeAlD
Epinephrine—Hyperglycaemia—Didanosine—acquired immunodeficiency syndrome	0.000521	0.0044	CcSEcCtD
Epinephrine—Renal impairment—Indinavir—acquired immunodeficiency syndrome	0.000493	0.00416	CcSEcCtD
Epinephrine—Disorientation—Delavirdine—acquired immunodeficiency syndrome	0.000474	0.004	CcSEcCtD
Epinephrine—Hyperglycaemia—Nevirapine—acquired immunodeficiency syndrome	0.000468	0.00395	CcSEcCtD
Epinephrine—Renal impairment—Efavirenz—acquired immunodeficiency syndrome	0.000465	0.00393	CcSEcCtD
Epinephrine—Lightheadedness—Saquinavir—acquired immunodeficiency syndrome	0.000465	0.00393	CcSEcCtD
Epinephrine—ADRA1B—nervous system—acquired immunodeficiency syndrome	0.000462	0.0123	CbGeAlD
Epinephrine—Hypoaesthesia—Didanosine—acquired immunodeficiency syndrome	0.00046	0.00388	CcSEcCtD
Epinephrine—Renal failure—Nevirapine—acquired immunodeficiency syndrome	0.000455	0.00384	CcSEcCtD
Epinephrine—Hyperglycaemia—Nelfinavir—acquired immunodeficiency syndrome	0.000454	0.00383	CcSEcCtD
Epinephrine—Hyperglycaemia—Stavudine—acquired immunodeficiency syndrome	0.000452	0.00382	CcSEcCtD
Epinephrine—ADRA1D—nervous system—acquired immunodeficiency syndrome	0.000452	0.012	CbGeAlD
Epinephrine—Hyperglycaemia—Abacavir—acquired immunodeficiency syndrome	0.000445	0.00376	CcSEcCtD
Epinephrine—ADRA1B—central nervous system—acquired immunodeficiency syndrome	0.000444	0.0118	CbGeAlD
Epinephrine—Mental disorder—Amprenavir—acquired immunodeficiency syndrome	0.000444	0.00375	CcSEcCtD
Epinephrine—SLC22A5—retina—acquired immunodeficiency syndrome	0.000436	0.0116	CbGeAlD
Epinephrine—ADRA1D—central nervous system—acquired immunodeficiency syndrome	0.000435	0.0116	CbGeAlD
Epinephrine—Acute coronary syndrome—Abacavir—acquired immunodeficiency syndrome	0.000434	0.00367	CcSEcCtD
Epinephrine—Renal failure—Abacavir—acquired immunodeficiency syndrome	0.000433	0.00365	CcSEcCtD
Epinephrine—Psychotic disorder—Efavirenz—acquired immunodeficiency syndrome	0.000433	0.00365	CcSEcCtD
Epinephrine—Myocardial infarction—Abacavir—acquired immunodeficiency syndrome	0.000432	0.00364	CcSEcCtD
Epinephrine—Sweating—Nelfinavir—acquired immunodeficiency syndrome	0.00043	0.00363	CcSEcCtD
Epinephrine—Sweating—Stavudine—acquired immunodeficiency syndrome	0.000429	0.00362	CcSEcCtD
Epinephrine—Sweating increased—Zidovudine—acquired immunodeficiency syndrome	0.000424	0.00358	CcSEcCtD
Epinephrine—SLC22A1—blood—acquired immunodeficiency syndrome	0.00042	0.0112	CbGeAlD
Epinephrine—Renal impairment—Ritonavir—acquired immunodeficiency syndrome	0.000412	0.00348	CcSEcCtD
Epinephrine—Haemoglobin—Nelfinavir—acquired immunodeficiency syndrome	0.000405	0.00342	CcSEcCtD
Epinephrine—Hypokalaemia—Efavirenz—acquired immunodeficiency syndrome	0.000403	0.0034	CcSEcCtD
Epinephrine—Haemorrhage—Nelfinavir—acquired immunodeficiency syndrome	0.000402	0.0034	CcSEcCtD
Epinephrine—Hypoaesthesia—Stavudine—acquired immunodeficiency syndrome	0.000399	0.00337	CcSEcCtD
Epinephrine—Renal impairment—Saquinavir—acquired immunodeficiency syndrome	0.000396	0.00335	CcSEcCtD
Epinephrine—SLC22A1—vagina—acquired immunodeficiency syndrome	0.000389	0.0104	CbGeAlD
Epinephrine—Hypoglycaemia—Saquinavir—acquired immunodeficiency syndrome	0.000387	0.00326	CcSEcCtD
Epinephrine—Cerebrovascular accident—Saquinavir—acquired immunodeficiency syndrome	0.000385	0.00325	CcSEcCtD
Epinephrine—SLC22A5—skin of body—acquired immunodeficiency syndrome	0.000383	0.0102	CbGeAlD
Epinephrine—Renal impairment—Lamivudine—acquired immunodeficiency syndrome	0.000378	0.00319	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Amprenavir—acquired immunodeficiency syndrome	0.000373	0.00315	CcSEcCtD
Epinephrine—Sweating increased—Efavirenz—acquired immunodeficiency syndrome	0.000373	0.00315	CcSEcCtD
Epinephrine—Sweating—Zidovudine—acquired immunodeficiency syndrome	0.000372	0.00314	CcSEcCtD
Epinephrine—Hypoglycaemia—Lamivudine—acquired immunodeficiency syndrome	0.000369	0.00311	CcSEcCtD
Epinephrine—Psychotic disorder—Saquinavir—acquired immunodeficiency syndrome	0.000368	0.00311	CcSEcCtD
Epinephrine—Hyperglycaemia—Indinavir—acquired immunodeficiency syndrome	0.000366	0.00309	CcSEcCtD
Epinephrine—Erythema—Nevirapine—acquired immunodeficiency syndrome	0.000362	0.00305	CcSEcCtD
Epinephrine—Sweating increased—Delavirdine—acquired immunodeficiency syndrome	0.000357	0.00301	CcSEcCtD
Epinephrine—Acute coronary syndrome—Indinavir—acquired immunodeficiency syndrome	0.000356	0.00301	CcSEcCtD
Epinephrine—Renal failure—Indinavir—acquired immunodeficiency syndrome	0.000355	0.003	CcSEcCtD
Epinephrine—ADRB1—lung—acquired immunodeficiency syndrome	0.000354	0.00943	CbGeAlD
Epinephrine—Myocardial infarction—Indinavir—acquired immunodeficiency syndrome	0.000354	0.00299	CcSEcCtD
Epinephrine—Nervous system disorder—Amprenavir—acquired immunodeficiency syndrome	0.000353	0.00298	CcSEcCtD
Epinephrine—ADRA1B—brain—acquired immunodeficiency syndrome	0.000353	0.00939	CbGeAlD
Epinephrine—Mental disorder—Stavudine—acquired immunodeficiency syndrome	0.000352	0.00297	CcSEcCtD
Epinephrine—Erythema—Nelfinavir—acquired immunodeficiency syndrome	0.00035	0.00296	CcSEcCtD
Epinephrine—Skin disorder—Amprenavir—acquired immunodeficiency syndrome	0.00035	0.00295	CcSEcCtD
Epinephrine—Sweating—Indinavir—acquired immunodeficiency syndrome	0.000346	0.00292	CcSEcCtD
Epinephrine—Hyperglycaemia—Efavirenz—acquired immunodeficiency syndrome	0.000345	0.00292	CcSEcCtD
Epinephrine—ADRA1D—brain—acquired immunodeficiency syndrome	0.000345	0.00919	CbGeAlD
Epinephrine—Hypokalaemia—Saquinavir—acquired immunodeficiency syndrome	0.000343	0.0029	CcSEcCtD
Epinephrine—Drowsiness—Efavirenz—acquired immunodeficiency syndrome	0.000341	0.00288	CcSEcCtD
Epinephrine—SLC22A1—nervous system—acquired immunodeficiency syndrome	0.000341	0.00907	CbGeAlD
Epinephrine—ADRA1A—lymphoid tissue—acquired immunodeficiency syndrome	0.000339	0.00904	CbGeAlD
Epinephrine—Renal failure—Efavirenz—acquired immunodeficiency syndrome	0.000336	0.00283	CcSEcCtD
Epinephrine—Hyperglycaemia—Delavirdine—acquired immunodeficiency syndrome	0.00033	0.00279	CcSEcCtD
Epinephrine—ADRB1—nervous system—acquired immunodeficiency syndrome	0.000328	0.00873	CbGeAlD
Epinephrine—SLC22A1—central nervous system—acquired immunodeficiency syndrome	0.000328	0.00873	CbGeAlD
Epinephrine—Sweating—Efavirenz—acquired immunodeficiency syndrome	0.000327	0.00276	CcSEcCtD
Epinephrine—Haemoglobin—Indinavir—acquired immunodeficiency syndrome	0.000326	0.00275	CcSEcCtD
Epinephrine—Haemorrhage—Indinavir—acquired immunodeficiency syndrome	0.000324	0.00274	CcSEcCtD
Epinephrine—Paraesthesia—Amprenavir—acquired immunodeficiency syndrome	0.000323	0.00273	CcSEcCtD
Epinephrine—Hypoaesthesia—Indinavir—acquired immunodeficiency syndrome	0.000323	0.00272	CcSEcCtD
Epinephrine—Agitation—Nelfinavir—acquired immunodeficiency syndrome	0.000322	0.00272	CcSEcCtD
Epinephrine—ADRA1A—blood—acquired immunodeficiency syndrome	0.000319	0.0085	CbGeAlD
Epinephrine—Sweating increased—Saquinavir—acquired immunodeficiency syndrome	0.000318	0.00268	CcSEcCtD
Epinephrine—ADRB1—central nervous system—acquired immunodeficiency syndrome	0.000316	0.0084	CbGeAlD
Epinephrine—Gastrointestinal disorder—Amprenavir—acquired immunodeficiency syndrome	0.000311	0.00263	CcSEcCtD
Epinephrine—SLC22A5—digestive system—acquired immunodeficiency syndrome	0.000306	0.00815	CbGeAlD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Nevirapine—acquired immunodeficiency syndrome	0.000306	0.00258	CcSEcCtD
Epinephrine—Hyperglycaemia—Ritonavir—acquired immunodeficiency syndrome	0.000306	0.00258	CcSEcCtD
Epinephrine—Mental disorder—Zidovudine—acquired immunodeficiency syndrome	0.000306	0.00258	CcSEcCtD
Epinephrine—Hypoaesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000305	0.00257	CcSEcCtD
Epinephrine—Hallucination—Efavirenz—acquired immunodeficiency syndrome	0.000305	0.00257	CcSEcCtD
Epinephrine—ADRA2C—blood—acquired immunodeficiency syndrome	0.000304	0.0081	CbGeAlD
Epinephrine—Erythema—Zidovudine—acquired immunodeficiency syndrome	0.000304	0.00256	CcSEcCtD
Epinephrine—Sweating increased—Lamivudine—acquired immunodeficiency syndrome	0.000303	0.00256	CcSEcCtD
Epinephrine—Flushing—Indinavir—acquired immunodeficiency syndrome	0.000301	0.00254	CcSEcCtD
Epinephrine—Tension—Zidovudine—acquired immunodeficiency syndrome	0.000298	0.00252	CcSEcCtD
Epinephrine—Acute coronary syndrome—Ritonavir—acquired immunodeficiency syndrome	0.000298	0.00251	CcSEcCtD
Epinephrine—Renal failure—Ritonavir—acquired immunodeficiency syndrome	0.000297	0.00251	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Nelfinavir—acquired immunodeficiency syndrome	0.000296	0.0025	CcSEcCtD
Epinephrine—Myocardial infarction—Ritonavir—acquired immunodeficiency syndrome	0.000296	0.0025	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Stavudine—acquired immunodeficiency syndrome	0.000295	0.00249	CcSEcCtD
Epinephrine—Nervousness—Zidovudine—acquired immunodeficiency syndrome	0.000295	0.00249	CcSEcCtD
Epinephrine—Paraesthesia—Didanosine—acquired immunodeficiency syndrome	0.000295	0.00249	CcSEcCtD
Epinephrine—Hyperglycaemia—Saquinavir—acquired immunodeficiency syndrome	0.000294	0.00248	CcSEcCtD
Epinephrine—ADRA2C—spinal cord—acquired immunodeficiency syndrome	0.000293	0.00781	CbGeAlD
Epinephrine—Hallucination—Delavirdine—acquired immunodeficiency syndrome	0.000292	0.00246	CcSEcCtD
Epinephrine—Hypoaesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000292	0.00246	CcSEcCtD
Epinephrine—SLC22A5—blood—acquired immunodeficiency syndrome	0.000292	0.00776	CbGeAlD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Abacavir—acquired immunodeficiency syndrome	0.000291	0.00246	CcSEcCtD
Epinephrine—Sweating—Ritonavir—acquired immunodeficiency syndrome	0.00029	0.00244	CcSEcCtD
Epinephrine—Nervous system disorder—Nevirapine—acquired immunodeficiency syndrome	0.00029	0.00244	CcSEcCtD
Epinephrine—Skin disorder—Nevirapine—acquired immunodeficiency syndrome	0.000287	0.00242	CcSEcCtD
Epinephrine—Renal failure—Saquinavir—acquired immunodeficiency syndrome	0.000286	0.00241	CcSEcCtD
Epinephrine—Flushing—Efavirenz—acquired immunodeficiency syndrome	0.000284	0.0024	CcSEcCtD
Epinephrine—ADRA2C—vagina—acquired immunodeficiency syndrome	0.000282	0.00751	CbGeAlD
Epinephrine—SLC22A5—spinal cord—acquired immunodeficiency syndrome	0.000281	0.00748	CbGeAlD
Epinephrine—Hyperglycaemia—Lamivudine—acquired immunodeficiency syndrome	0.000281	0.00237	CcSEcCtD
Epinephrine—Nervous system disorder—Stavudine—acquired immunodeficiency syndrome	0.00028	0.00236	CcSEcCtD
Epinephrine—Skin disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000278	0.00235	CcSEcCtD
Epinephrine—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000277	0.00738	CbGeAlD
Epinephrine—Tension—Indinavir—acquired immunodeficiency syndrome	0.000277	0.00234	CcSEcCtD
Epinephrine—Skin disorder—Stavudine—acquired immunodeficiency syndrome	0.000277	0.00234	CcSEcCtD
Epinephrine—Hyperhidrosis—Nelfinavir—acquired immunodeficiency syndrome	0.000276	0.00233	CcSEcCtD
Epinephrine—Hyperhidrosis—Stavudine—acquired immunodeficiency syndrome	0.000276	0.00233	CcSEcCtD
Epinephrine—Nervous system disorder—Abacavir—acquired immunodeficiency syndrome	0.000275	0.00233	CcSEcCtD
Epinephrine—Nervousness—Indinavir—acquired immunodeficiency syndrome	0.000274	0.00232	CcSEcCtD
Epinephrine—Arrhythmia—Efavirenz—acquired immunodeficiency syndrome	0.000274	0.00231	CcSEcCtD
Epinephrine—Skin disorder—Abacavir—acquired immunodeficiency syndrome	0.000273	0.0023	CcSEcCtD
Epinephrine—Renal failure—Lamivudine—acquired immunodeficiency syndrome	0.000273	0.0023	CcSEcCtD
Epinephrine—Haemoglobin—Ritonavir—acquired immunodeficiency syndrome	0.000273	0.0023	CcSEcCtD
Epinephrine—Haemorrhage—Ritonavir—acquired immunodeficiency syndrome	0.000271	0.00229	CcSEcCtD
Epinephrine—SLC22A5—vagina—acquired immunodeficiency syndrome	0.00027	0.00719	CbGeAlD
Epinephrine—Hypoaesthesia—Ritonavir—acquired immunodeficiency syndrome	0.00027	0.00228	CcSEcCtD
Epinephrine—Hallucination—Ritonavir—acquired immunodeficiency syndrome	0.00027	0.00228	CcSEcCtD
Epinephrine—ADRA2C—lung—acquired immunodeficiency syndrome	0.000267	0.0071	CbGeAlD
Epinephrine—Erythema—Efavirenz—acquired immunodeficiency syndrome	0.000267	0.00225	CcSEcCtD
Epinephrine—Sweating—Lamivudine—acquired immunodeficiency syndrome	0.000266	0.00224	CcSEcCtD
Epinephrine—Paraesthesia—Nevirapine—acquired immunodeficiency syndrome	0.000265	0.00224	CcSEcCtD
Epinephrine—CYP1A2—blood—acquired immunodeficiency syndrome	0.000264	0.00703	CbGeAlD
Epinephrine—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000263	0.00701	CbGeAlD
Epinephrine—Somnolence—Nevirapine—acquired immunodeficiency syndrome	0.000262	0.00222	CcSEcCtD
Epinephrine—Haemoglobin—Saquinavir—acquired immunodeficiency syndrome	0.000262	0.00221	CcSEcCtD
Epinephrine—Tension—Efavirenz—acquired immunodeficiency syndrome	0.000262	0.00221	CcSEcCtD
Epinephrine—Haemorrhage—Saquinavir—acquired immunodeficiency syndrome	0.000261	0.0022	CcSEcCtD
Epinephrine—SLC22A1—brain—acquired immunodeficiency syndrome	0.00026	0.00693	CbGeAlD
Epinephrine—Hypoaesthesia—Saquinavir—acquired immunodeficiency syndrome	0.00026	0.00219	CcSEcCtD
Epinephrine—Hallucination—Saquinavir—acquired immunodeficiency syndrome	0.00026	0.00219	CcSEcCtD
Epinephrine—Agitation—Indinavir—acquired immunodeficiency syndrome	0.000259	0.00219	CcSEcCtD
Epinephrine—ADRA1A—nervous system—acquired immunodeficiency syndrome	0.000259	0.0069	CbGeAlD
Epinephrine—Nervousness—Efavirenz—acquired immunodeficiency syndrome	0.000259	0.00219	CcSEcCtD
Epinephrine—Insomnia—Nelfinavir—acquired immunodeficiency syndrome	0.000259	0.00218	CcSEcCtD
Epinephrine—Chest pain—Zidovudine—acquired immunodeficiency syndrome	0.000258	0.00218	CcSEcCtD
Epinephrine—Insomnia—Stavudine—acquired immunodeficiency syndrome	0.000258	0.00218	CcSEcCtD
Epinephrine—Paraesthesia—Nelfinavir—acquired immunodeficiency syndrome	0.000257	0.00217	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Zidovudine—acquired immunodeficiency syndrome	0.000257	0.00217	CcSEcCtD
Epinephrine—Paraesthesia—Stavudine—acquired immunodeficiency syndrome	0.000256	0.00216	CcSEcCtD
Epinephrine—SLC22A5—lung—acquired immunodeficiency syndrome	0.000256	0.0068	CbGeAlD
Epinephrine—Erythema—Delavirdine—acquired immunodeficiency syndrome	0.000255	0.00216	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.000255	0.00215	CcSEcCtD
Epinephrine—Somnolence—Nelfinavir—acquired immunodeficiency syndrome	0.000254	0.00215	CcSEcCtD
Epinephrine—Insomnia—Abacavir—acquired immunodeficiency syndrome	0.000254	0.00214	CcSEcCtD
Epinephrine—Somnolence—Stavudine—acquired immunodeficiency syndrome	0.000253	0.00214	CcSEcCtD
Epinephrine—Paraesthesia—Abacavir—acquired immunodeficiency syndrome	0.000252	0.00213	CcSEcCtD
Epinephrine—Flushing—Ritonavir—acquired immunodeficiency syndrome	0.000252	0.00212	CcSEcCtD
Epinephrine—CYP2C9—blood—acquired immunodeficiency syndrome	0.000251	0.00667	CbGeAlD
Epinephrine—ADRB1—brain—acquired immunodeficiency syndrome	0.000251	0.00667	CbGeAlD
Epinephrine—Tension—Delavirdine—acquired immunodeficiency syndrome	0.00025	0.00211	CcSEcCtD
Epinephrine—ADRA1A—central nervous system—acquired immunodeficiency syndrome	0.00025	0.00665	CbGeAlD
Epinephrine—Palpitations—Indinavir—acquired immunodeficiency syndrome	0.00025	0.00211	CcSEcCtD
Epinephrine—Nervousness—Delavirdine—acquired immunodeficiency syndrome	0.000248	0.00209	CcSEcCtD
Epinephrine—Hypoaesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000248	0.00209	CcSEcCtD
Epinephrine—ADRA2C—nervous system—acquired immunodeficiency syndrome	0.000247	0.00658	CbGeAlD
Epinephrine—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000247	0.00208	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.000246	0.00208	CcSEcCtD
Epinephrine—Agitation—Efavirenz—acquired immunodeficiency syndrome	0.000245	0.00207	CcSEcCtD
Epinephrine—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.000243	0.00205	CcSEcCtD
Epinephrine—ADRA2A—blood—acquired immunodeficiency syndrome	0.000243	0.00646	CbGeAlD
Epinephrine—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.000242	0.00205	CcSEcCtD
Epinephrine—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.000241	0.00203	CcSEcCtD
Epinephrine—Chest pain—Indinavir—acquired immunodeficiency syndrome	0.00024	0.00203	CcSEcCtD
Epinephrine—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.00024	0.00202	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.000239	0.00202	CcSEcCtD
Epinephrine—ADRA2C—central nervous system—acquired immunodeficiency syndrome	0.000238	0.00633	CbGeAlD
Epinephrine—Mental disorder—Ritonavir—acquired immunodeficiency syndrome	0.000238	0.00201	CcSEcCtD
Epinephrine—Palpitations—Efavirenz—acquired immunodeficiency syndrome	0.000236	0.00199	CcSEcCtD
Epinephrine—Agitation—Delavirdine—acquired immunodeficiency syndrome	0.000235	0.00198	CcSEcCtD
Epinephrine—ADRA2A—spinal cord—acquired immunodeficiency syndrome	0.000234	0.00623	CbGeAlD
Epinephrine—Tension—Ritonavir—acquired immunodeficiency syndrome	0.000232	0.00196	CcSEcCtD
Epinephrine—CYP1A2—lung—acquired immunodeficiency syndrome	0.000232	0.00616	CbGeAlD
Epinephrine—Hypertension—Efavirenz—acquired immunodeficiency syndrome	0.00023	0.00194	CcSEcCtD
Epinephrine—Nervousness—Ritonavir—acquired immunodeficiency syndrome	0.000229	0.00194	CcSEcCtD
Epinephrine—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000229	0.00193	CcSEcCtD
Epinephrine—Mental disorder—Saquinavir—acquired immunodeficiency syndrome	0.000229	0.00193	CcSEcCtD
Epinephrine—Erythema—Saquinavir—acquired immunodeficiency syndrome	0.000227	0.00192	CcSEcCtD
Epinephrine—Chest pain—Efavirenz—acquired immunodeficiency syndrome	0.000227	0.00192	CcSEcCtD
Epinephrine—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.000226	0.00191	CcSEcCtD
Epinephrine—Palpitations—Delavirdine—acquired immunodeficiency syndrome	0.000226	0.0019	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.000226	0.0019	CcSEcCtD
Epinephrine—ADRA2A—vagina—acquired immunodeficiency syndrome	0.000225	0.00599	CbGeAlD
Epinephrine—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.000224	0.00189	CcSEcCtD
Epinephrine—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.000224	0.00189	CcSEcCtD
Epinephrine—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.000223	0.00188	CcSEcCtD
Epinephrine—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.000222	0.00188	CcSEcCtD
Epinephrine—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.00022	0.00186	CcSEcCtD
Epinephrine—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.00022	0.00186	CcSEcCtD
Epinephrine—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.000217	0.00183	CcSEcCtD
Epinephrine—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.000217	0.00183	CcSEcCtD
Epinephrine—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.000217	0.00183	CcSEcCtD
Epinephrine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000214	0.00181	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000214	0.00181	CcSEcCtD
Epinephrine—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000214	0.0018	CcSEcCtD
Epinephrine—ADRA2A—lung—acquired immunodeficiency syndrome	0.000213	0.00567	CbGeAlD
Epinephrine—Tension—Lamivudine—acquired immunodeficiency syndrome	0.000213	0.0018	CcSEcCtD
Epinephrine—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000212	0.00179	CcSEcCtD
Epinephrine—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000211	0.00179	CcSEcCtD
Epinephrine—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.00021	0.00178	CcSEcCtD
Epinephrine—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.00021	0.00178	CcSEcCtD
Epinephrine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000209	0.00176	CcSEcCtD
Epinephrine—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000209	0.00176	CcSEcCtD
Epinephrine—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000209	0.00176	CcSEcCtD
Epinephrine—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000208	0.00176	CcSEcCtD
Epinephrine—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000207	0.00175	CcSEcCtD
Epinephrine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000205	0.00173	CcSEcCtD
Epinephrine—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000204	0.00172	CcSEcCtD
Epinephrine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000203	0.00172	CcSEcCtD
Epinephrine—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000202	0.00171	CcSEcCtD
Epinephrine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000201	0.0017	CcSEcCtD
Epinephrine—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000201	0.0017	CcSEcCtD
Epinephrine—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000201	0.00534	CbGeAlD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.0002	0.00169	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000199	0.00168	CcSEcCtD
Epinephrine—ADRA1A—brain—acquired immunodeficiency syndrome	0.000198	0.00528	CbGeAlD
Epinephrine—ADRA2A—nervous system—acquired immunodeficiency syndrome	0.000197	0.00525	CbGeAlD
Epinephrine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000197	0.00166	CcSEcCtD
Epinephrine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000196	0.00166	CcSEcCtD
Epinephrine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000195	0.00165	CcSEcCtD
Epinephrine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000195	0.00165	CcSEcCtD
Epinephrine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000194	0.00163	CcSEcCtD
Epinephrine—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000193	0.00163	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000192	0.00162	CcSEcCtD
Epinephrine—CYP3A4—blood—acquired immunodeficiency syndrome	0.000191	0.00509	CbGeAlD
Epinephrine—ADRA2A—central nervous system—acquired immunodeficiency syndrome	0.00019	0.00505	CbGeAlD
Epinephrine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000189	0.0016	CcSEcCtD
Epinephrine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000189	0.0016	CcSEcCtD
Epinephrine—ADRA2C—brain—acquired immunodeficiency syndrome	0.000189	0.00503	CbGeAlD
Epinephrine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000189	0.00159	CcSEcCtD
Epinephrine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000188	0.00159	CcSEcCtD
Epinephrine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000188	0.00159	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000188	0.00159	CcSEcCtD
Epinephrine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000188	0.00159	CcSEcCtD
Epinephrine—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000187	0.00158	CcSEcCtD
Epinephrine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000187	0.00158	CcSEcCtD
Epinephrine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000186	0.00157	CcSEcCtD
Epinephrine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000186	0.00157	CcSEcCtD
Epinephrine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000185	0.00156	CcSEcCtD
Epinephrine—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000185	0.00156	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000183	0.00155	CcSEcCtD
Epinephrine—ADRA2C—lymph node—acquired immunodeficiency syndrome	0.000183	0.00486	CbGeAlD
Epinephrine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000182	0.00154	CcSEcCtD
Epinephrine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000182	0.00154	CcSEcCtD
Epinephrine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000181	0.00153	CcSEcCtD
Epinephrine—SLC22A5—brain—acquired immunodeficiency syndrome	0.000181	0.00482	CbGeAlD
Epinephrine—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.00018	0.00152	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.00018	0.00152	CcSEcCtD
Epinephrine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000179	0.00151	CcSEcCtD
Epinephrine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000179	0.00151	CcSEcCtD
Epinephrine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000175	0.00148	CcSEcCtD
Epinephrine—SLC22A5—lymph node—acquired immunodeficiency syndrome	0.000175	0.00465	CbGeAlD
Epinephrine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000174	0.00147	CcSEcCtD
Epinephrine—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000173	0.00146	CcSEcCtD
Epinephrine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000173	0.00146	CcSEcCtD
Epinephrine—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000172	0.00145	CcSEcCtD
Epinephrine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000171	0.00145	CcSEcCtD
Epinephrine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000171	0.00144	CcSEcCtD
Epinephrine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00017	0.00143	CcSEcCtD
Epinephrine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000169	0.00143	CcSEcCtD
Epinephrine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000168	0.00142	CcSEcCtD
Epinephrine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000167	0.00141	CcSEcCtD
Epinephrine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000166	0.00141	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000166	0.0014	CcSEcCtD
Epinephrine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000165	0.00139	CcSEcCtD
Epinephrine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000164	0.00138	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.00016	0.00135	CcSEcCtD
Epinephrine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.00016	0.00135	CcSEcCtD
Epinephrine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000159	0.00134	CcSEcCtD
Epinephrine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000158	0.00133	CcSEcCtD
Epinephrine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000157	0.00133	CcSEcCtD
Epinephrine—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000155	0.00413	CbGeAlD
Epinephrine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000153	0.00129	CcSEcCtD
Epinephrine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000152	0.00129	CcSEcCtD
Epinephrine—ADRA2A—brain—acquired immunodeficiency syndrome	0.000151	0.00401	CbGeAlD
Epinephrine—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000149	0.00398	CbGeAlD
Epinephrine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000147	0.00124	CcSEcCtD
Epinephrine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000147	0.00124	CcSEcCtD
Epinephrine—ADRA2A—lymph node—acquired immunodeficiency syndrome	0.000146	0.00388	CbGeAlD
Epinephrine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000144	0.00122	CcSEcCtD
Epinephrine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000138	0.00117	CcSEcCtD
Epinephrine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000138	0.00116	CcSEcCtD
Epinephrine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000137	0.00116	CcSEcCtD
Epinephrine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000132	0.00112	CcSEcCtD
Epinephrine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000129	0.00109	CcSEcCtD
Epinephrine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000127	0.00108	CcSEcCtD
Epinephrine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000124	0.00104	CcSEcCtD
Epinephrine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000123	0.00104	CcSEcCtD
Epinephrine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000122	0.00103	CcSEcCtD
Epinephrine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.000995	CcSEcCtD
Epinephrine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000117	0.000988	CcSEcCtD
Epinephrine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000114	0.000966	CcSEcCtD
Epinephrine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000112	0.00095	CcSEcCtD
Epinephrine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00011	0.00093	CcSEcCtD
Epinephrine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.000887	CcSEcCtD
Epinephrine—ADRA1B—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	2.35e-05	0.00047	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.34e-05	0.000469	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.33e-05	0.000467	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.32e-05	0.000464	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	2.29e-05	0.000459	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	2.29e-05	0.000459	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.29e-05	0.000459	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	2.26e-05	0.000451	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	2.26e-05	0.000451	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	2.25e-05	0.000449	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	2.25e-05	0.000449	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.24e-05	0.000448	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.22e-05	0.000444	CbGpPWpGaD
Epinephrine—ADRA2A—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	2.22e-05	0.000444	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	2.21e-05	0.000443	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	2.21e-05	0.000442	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	2.21e-05	0.000442	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.2e-05	0.000441	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.2e-05	0.000441	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.19e-05	0.000439	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.19e-05	0.000439	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.19e-05	0.000438	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.18e-05	0.000437	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.18e-05	0.000437	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.17e-05	0.000434	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—CSF2—acquired immunodeficiency syndrome	2.16e-05	0.000433	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.16e-05	0.000431	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.16e-05	0.000431	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.14e-05	0.000427	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—TAT—acquired immunodeficiency syndrome	2.12e-05	0.000423	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	2.1e-05	0.000419	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	2.09e-05	0.000418	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.08e-05	0.000416	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.07e-05	0.000415	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.05e-05	0.000409	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.04e-05	0.000408	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.04e-05	0.000408	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.04e-05	0.000408	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.03e-05	0.000405	CbGpPWpGaD
Epinephrine—ADRBK1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.02e-05	0.000403	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.01e-05	0.000401	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.01e-05	0.000401	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	2.01e-05	0.000401	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	2.01e-05	0.000401	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2e-05	0.000399	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	1.96e-05	0.000393	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	1.96e-05	0.000393	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	1.95e-05	0.00039	CbGpPWpGaD
Epinephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.95e-05	0.000389	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	1.94e-05	0.000388	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	1.9e-05	0.000379	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—IFNG—acquired immunodeficiency syndrome	1.88e-05	0.000377	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.87e-05	0.000374	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	1.86e-05	0.000373	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	1.86e-05	0.000373	CbGpPWpGaD
Epinephrine—ADRA2B—Hemostasis—ALB—acquired immunodeficiency syndrome	1.86e-05	0.000372	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.85e-05	0.000369	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.84e-05	0.000368	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.83e-05	0.000366	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.83e-05	0.000366	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.83e-05	0.000365	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	1.82e-05	0.000365	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	1.82e-05	0.000365	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—CD4—acquired immunodeficiency syndrome	1.82e-05	0.000364	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.82e-05	0.000364	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.81e-05	0.000363	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.81e-05	0.000362	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—TAT—acquired immunodeficiency syndrome	1.81e-05	0.000362	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.81e-05	0.000361	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.8e-05	0.00036	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—AGPS—acquired immunodeficiency syndrome	1.8e-05	0.00036	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	1.78e-05	0.000357	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	1.78e-05	0.000357	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.78e-05	0.000356	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	1.76e-05	0.000352	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—ALB—acquired immunodeficiency syndrome	1.74e-05	0.000347	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.71e-05	0.000342	CbGpPWpGaD
Epinephrine—ADRBK1—Innate Immune System—IL6—acquired immunodeficiency syndrome	1.69e-05	0.000338	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.69e-05	0.000337	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.68e-05	0.000337	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.68e-05	0.000336	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.68e-05	0.000336	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—CD4—acquired immunodeficiency syndrome	1.68e-05	0.000336	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.68e-05	0.000335	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—IL2—acquired immunodeficiency syndrome	1.67e-05	0.000335	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.67e-05	0.000334	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.66e-05	0.000333	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.66e-05	0.000332	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.66e-05	0.000332	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	1.66e-05	0.000331	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	1.66e-05	0.000331	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.66e-05	0.000331	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.65e-05	0.00033	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.65e-05	0.00033	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.64e-05	0.000329	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.64e-05	0.000328	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.64e-05	0.000327	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.63e-05	0.000325	CbGpPWpGaD
Epinephrine—ADRB3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.62e-05	0.000324	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.62e-05	0.000323	CbGpPWpGaD
Epinephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.62e-05	0.000323	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.55e-05	0.00031	CbGpPWpGaD
Epinephrine—SLC22A2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.55e-05	0.000309	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.54e-05	0.000308	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	1.54e-05	0.000308	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.53e-05	0.000306	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.53e-05	0.000306	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.53e-05	0.000305	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.52e-05	0.000304	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.52e-05	0.000303	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.52e-05	0.000303	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.51e-05	0.000302	CbGpPWpGaD
Epinephrine—ADRA2B—Hemostasis—IL2—acquired immunodeficiency syndrome	1.51e-05	0.000301	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.5e-05	0.000301	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.5e-05	0.000301	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.5e-05	0.0003	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.5e-05	0.000299	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.49e-05	0.000299	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.48e-05	0.000295	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.47e-05	0.000294	CbGpPWpGaD
Epinephrine—ADRB3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.47e-05	0.000294	CbGpPWpGaD
Epinephrine—SLC22A1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.44e-05	0.000288	CbGpPWpGaD
Epinephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.43e-05	0.000287	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.43e-05	0.000286	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.43e-05	0.000286	CbGpPWpGaD
Epinephrine—PAH—Disease—IL6—acquired immunodeficiency syndrome	1.43e-05	0.000285	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.42e-05	0.000283	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—ALB—acquired immunodeficiency syndrome	1.41e-05	0.000282	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—IL2—acquired immunodeficiency syndrome	1.41e-05	0.000281	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.4e-05	0.00028	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	1.4e-05	0.000279	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.39e-05	0.000279	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.39e-05	0.000278	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.38e-05	0.000277	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.38e-05	0.000275	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.37e-05	0.000274	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.37e-05	0.000273	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.36e-05	0.000271	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.35e-05	0.000271	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.35e-05	0.000269	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.34e-05	0.000267	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.3e-05	0.00026	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.3e-05	0.00026	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.29e-05	0.000258	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.29e-05	0.000258	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.28e-05	0.000256	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.27e-05	0.000255	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.27e-05	0.000255	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.26e-05	0.000252	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.26e-05	0.000252	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.25e-05	0.00025	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.24e-05	0.000248	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.24e-05	0.000248	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.22e-05	0.000244	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.21e-05	0.000241	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.21e-05	0.000241	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	1.19e-05	0.000237	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.19e-05	0.000237	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.19e-05	0.000237	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.15e-05	0.00023	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—IL2—acquired immunodeficiency syndrome	1.14e-05	0.000229	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.14e-05	0.000227	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.12e-05	0.000224	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.09e-05	0.000217	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.08e-05	0.000216	CbGpPWpGaD
Epinephrine—TNF—Developmental Biology—IL6—acquired immunodeficiency syndrome	1.08e-05	0.000216	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.08e-05	0.000215	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.07e-05	0.000214	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.05e-05	0.000211	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.05e-05	0.000211	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.05e-05	0.000211	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.04e-05	0.000208	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.91e-06	0.000198	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—IL6—acquired immunodeficiency syndrome	9.84e-06	0.000197	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.82e-06	0.000196	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.79e-06	0.000196	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	9.79e-06	0.000196	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	9.79e-06	0.000196	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.76e-06	0.000195	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.69e-06	0.000194	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.67e-06	0.000193	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.61e-06	0.000192	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.58e-06	0.000192	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.54e-06	0.000191	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.52e-06	0.00019	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.4e-06	0.000188	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.17e-06	0.000183	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—IL6—acquired immunodeficiency syndrome	9.08e-06	0.000182	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.03e-06	0.000181	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.02e-06	0.00018	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.92e-06	0.000178	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.9e-06	0.000178	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.89e-06	0.000178	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.84e-06	0.000177	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.76e-06	0.000175	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.73e-06	0.000175	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.73e-06	0.000175	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.69e-06	0.000174	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.65e-06	0.000173	CbGpPWpGaD
Epinephrine—ADRB3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.64e-06	0.000173	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.54e-06	0.000171	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	8.29e-06	0.000166	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.26e-06	0.000165	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.13e-06	0.000163	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.08e-06	0.000162	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.02e-06	0.00016	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.95e-06	0.000159	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.9e-06	0.000158	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.78e-06	0.000156	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.45e-06	0.000149	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.34e-06	0.000147	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—ALB—acquired immunodeficiency syndrome	7.24e-06	0.000145	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.23e-06	0.000144	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.22e-06	0.000144	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	7.09e-06	0.000142	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.06e-06	0.000141	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—ALB—acquired immunodeficiency syndrome	7.04e-06	0.000141	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—ALB—acquired immunodeficiency syndrome	6.75e-06	0.000135	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.71e-06	0.000134	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.56e-06	0.000131	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.36e-06	0.000127	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—ALB—acquired immunodeficiency syndrome	5.72e-06	0.000114	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.66e-06	0.000113	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.63e-06	0.000113	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.16e-06	0.000103	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.13e-06	0.000103	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.11e-06	0.000102	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.11e-06	0.000102	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.08e-06	0.000102	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.04e-06	0.000101	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.02e-06	0.0001	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.77e-06	9.54e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.75e-06	9.5e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.7e-06	9.39e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.67e-06	9.35e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.17e-06	8.34e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.15e-06	8.3e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.88e-06	7.75e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.86e-06	7.71e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	3.69e-06	7.38e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.33e-06	6.65e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—ALB—acquired immunodeficiency syndrome	3.16e-06	6.31e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.03e-06	6.06e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3e-06	6e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.96e-06	5.93e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.81e-06	5.61e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.76e-06	5.52e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.45e-06	4.9e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	2.44e-06	4.87e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.28e-06	4.56e-05	CbGpPWpGaD
